Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
743.40 EUR | -0.61% | +4.32% | +9.55% |
01-17 | Dutch government excludes most ASML sales to China from 'dual use' export data | RE |
01-17 | ASML : Berenberg remains its Buy rating | ZD |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 11.82B | 13.98B | 18.61B | 21.17B | 27.56B | |||||
Total Revenues | 11.82B | 13.98B | 18.61B | 21.17B | 27.56B | |||||
Cost of Goods Sold, Total | 6.54B | 7.18B | 8.8B | 10.47B | 13.42B | |||||
Gross Profit | 5.28B | 6.8B | 9.81B | 10.7B | 14.14B | |||||
Selling General & Admin Expenses, Total | 520M | 540M | 726M | 946M | 1.11B | |||||
R&D Expenses | 1.97B | 2.2B | 2.55B | 3.25B | 3.98B | |||||
Other Operating Expenses | - | - | - | - | - | |||||
Other Operating Expenses, Total | 2.49B | 2.74B | 3.27B | 4.2B | 5.09B | |||||
Operating Income | 2.79B | 4.06B | 6.54B | 6.5B | 9.04B | |||||
Interest Expense, Total | -36.6M | -43.3M | -54.6M | -60.8M | -153M | |||||
Interest And Investment Income | 11.6M | 8.4M | 10M | 16.2M | 194M | |||||
Net Interest Expenses | -25M | -34.9M | -44.6M | -44.6M | 41.2M | |||||
Income (Loss) On Equity Invest. | 18.2M | 88.6M | 199M | 138M | 191M | |||||
Other Non Operating Income (Expenses) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | 2.78B | 4.11B | 6.69B | 6.59B | 9.27B | |||||
Merger & Related Restructuring Charges | - | -5.4M | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | 214M | - | - | |||||
EBT, Incl. Unusual Items | 2.78B | 4.11B | 6.9B | 6.59B | 9.27B | |||||
Income Tax Expense | 192M | 552M | 1.02B | 970M | 1.44B | |||||
Earnings From Continuing Operations | 2.59B | 3.55B | 5.88B | 5.62B | 7.84B | |||||
Net Income to Company | 2.59B | 3.55B | 5.88B | 5.62B | 7.84B | |||||
Net Income - (IS) | 2.59B | 3.55B | 5.88B | 5.62B | 7.84B | |||||
Net Income to Common Incl Extra Items | 2.59B | 3.55B | 5.88B | 5.62B | 7.84B | |||||
Net Income to Common Excl. Extra Items | 2.59B | 3.55B | 5.88B | 5.62B | 7.84B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 6.16 | 8.5 | 14.36 | 14.14 | 19.91 | |||||
Basic EPS - Continuing Operations | 6.16 | 8.5 | 14.36 | 14.14 | 19.91 | |||||
Basic Weighted Average Shares Outstanding | 421M | 418M | 410M | 398M | 394M | |||||
Net EPS - Diluted | 6.15 | 8.48 | 14.34 | 14.13 | 19.89 | |||||
Diluted EPS - Continuing Operations | 6.15 | 8.48 | 14.34 | 14.13 | 19.89 | |||||
Diluted Weighted Average Shares Outstanding | 422M | 419M | 410M | 398M | 394M | |||||
Normalized Basic EPS | 4.13 | 6.14 | 10.2 | 10.36 | 14.72 | |||||
Normalized Diluted EPS | 4.13 | 6.13 | 10.19 | 10.36 | 14.71 | |||||
Dividend Per Share | 2.4 | 2.75 | 5.5 | 5.8 | 6.1 | |||||
Payout Ratio | 51.14 | 30.01 | 23.26 | 45.51 | 29.96 | |||||
American Depositary Receipts Ratio (ADR) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |||||
Supplemental Items | ||||||||||
EBITDA | 3.16B | 4.45B | 6.91B | 7B | 9.7B | |||||
EBITA | 2.82B | 4.1B | 6.59B | 6.55B | 9.09B | |||||
EBIT | 2.79B | 4.06B | 6.54B | 6.5B | 9.04B | |||||
EBITDAR | - | - | - | - | 9.75B | |||||
Total Revenues (As Reported) | 11.82B | 13.98B | 18.61B | 21.17B | 27.56B | |||||
Effective Tax Rate - (Ratio) | 6.89 | 13.43 | 14.79 | 14.71 | 15.48 | |||||
Current Domestic Taxes | 306M | 408M | 865M | 818M | 1.21B | |||||
Current Foreign Taxes | 118M | 375M | 524M | 678M | 441M | |||||
Total Current Taxes | 424M | 783M | 1.39B | 1.5B | 1.65B | |||||
Deferred Domestic Taxes | -74.8M | -1.4M | 28.6M | 44.4M | 58.4M | |||||
Deferred Foreign Taxes | -157M | -230M | -396M | -571M | -276M | |||||
Total Deferred Taxes | -232M | -232M | -367M | -527M | -217M | |||||
Normalized Net Income | 1.74B | 2.57B | 4.18B | 4.12B | 5.8B | |||||
Interest Capitalized | - | - | - | - | - | |||||
Interest on Long-Term Debt | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 2.04B | 2.27B | 2.62B | 3.32B | 4.04B | |||||
Net Rental Expense, Total | - | - | - | - | 53M | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | 13.39M | |||||
Imputed Operating Lease Depreciation | - | - | - | - | 39.61M | |||||
Stock-Based Comp., Other (Total) | 74.6M | 53.9M | 118M | 68.9M | 135M | |||||
Total Stock-Based Compensation | 74.6M | 53.9M | 118M | 68.9M | 135M |